Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
darunavir (prezista) (1 trial)
dolutegravir (tivicay) (1 trial)
lopinavir (Kaletra) (1 trial)
stavudine (zerit) (1 trial)
tenofovir (viread) (2 trials)
tenofovir alafenamide (genvoya) (1 trial)
Acquired Immunodeficiency Syndrome (Phase 3)
HIV Infections (Phase 3)
Immunologic Deficiency Syndromes (Phase 3)
Trials (3 total)
Trial APIs (6 total)